Peer-reviewed article

Psychedelic-Assisted Therapy: Breakthrough for Whom?

Psychiatric services (Washington, D.C.)Apr 1, 20261 citationsDOI: 10.1176/appi.ps.26077010

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinMDMA

Keywords

MedicaidMental Health EquityPsychedelic Assisted Thereapy

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticlePsilocybin

Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress.

Viña SM

Europe PMC2025

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026